Duke Cannon Standard Issue Face
NDC Package 60717-906-17

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Duke Cannon Standard Issue Face is a medication used as. Marketed by Rna Pharma, Llc, this product is identified by NDC 60717-906 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
60717-906-17
Package Description
50 mL in 1 TUBE
Product Code
60717-906
11-Digit Billing Format
60717090617

Clinical Specifications

Proprietary Name
Duke Cannon Standard Issue Face
Dosage Form
-
Usage Information
This product is used as

Regulatory & Marketing

Labeler Name
Rna Pharma, Llc
FDA Application #
part352
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
09-21-2021
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60717-906-17 identifies a specific commercial package of 50 ml in 1 tube of Duke Cannon Standard Issue Face, labeled by Rna Pharma, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rna Pharma, Llc on September 21, 2021. The current certification is valid through December 31, 2024.

How is this Rna Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60717090617. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60717-906-17
11-Digit CMS (5-4-2)
60717-0906-17

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.